Regulations.gov document
Appendix A - "Effects of Enoxaparin and Its Molecular Fractions on Endothelial Tissue…
Supporting & Related Material · FDA-2003-P-0273 · posted Jun 10, 2009
Key facts
| Document ID | FDA-2003-P-0273-0030 |
|---|---|
| Title | Appendix A - "Effects of Enoxaparin and Its Molecular Fractions on Endothelial Tissue Factor Pathway Inhibitor: Role of 1, 6 Anhydro," Study by S. Mousa, Ph.D." - [Aventis Pharmaceuticals, Inc., (Covington & Burling, LLP) - Supplement Citizen Petition (2)] re FDA-2003-P-0273-0008 |
| Document type | Supporting & Related Material |
| Subtype | SUP-Supplement (Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2003-P-0273 |
| Posted | Jun 10, 2009 |
| Effective date | Sep 26, 2005 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: